摘要:
Modified natriuretic compounds and conjugates thereof are disclosed in the present invention. In particular, conjugated forms of hBNP are provided that include at least one modifying moiety attached thereto. The modified natriuretic compound conjugates retain activity for stimulating cGMP production, binding to NPR-A receptor, and in some embodiments an improved half-life in circulation as compared to unmodified counterpart natriuretic compounds. Oral, parenteral, enteral, subcutaneous, pulmonary, and intravenous forms of the compounds and conjugates may be prepared as treatments and/or therapies for heart conditions particularly congestive heart failure. Modifying moieties comprising oligomeric structures having a variety of lengths and configurations are also disclosed. Analogs of the natriuretic compound are also disclosed, having an amino acid sequence that is other than the native sequence.
摘要:
A family of crystalline aluminosilicate zeolites designated UZM-8HS and derived from UZM-8 have been synthesized. The aluminum content of the UZM-8HS is lower than that of the starting UZM-8 thus changing its ion exchange capacity and acidity. These UZM-8HS are represented by the empirical formula: M1an+Al(1−x)ExSiy′Oz″ and are prepared by treatments such as acid extraction and AFS treatments.
摘要:
Example methods and devices are set forth for playing a game. In some embodiments, an inventory of game indicia is arranged in a random but established, serial order. In some embodiments, for each hand of play the player makes a wager and game indicia are displayed in order from the inventory to define a winning or losing outcome. In some embodiments, a display, as hands are played, displays the remaining constituency of the inventory and the player, before any game, can order re-shuffling and re-constitute of the inventory. Other embodiments are described.
摘要:
Fatty acid compositions for administration of of pharmaceutical agents, such as proteins and peptides, protein and peptide conjugates, and/or cation-polypeptide conjugate complexes. In particular, the invention provides a solid pharmaceutical composition formulated for oral administration by ingestion, having from about 0.1 to about 75% w/w fatty acid component, where the fatty acid component comprises saturated or unsaturated C4, C5, C6, C7, C8, C9, C10, C11, or C12 fatty acids and/or salts of such fatty acids; and a therapeutic agent. Further, the invention provides a liquid pharmaceutical composition formulated for oral administration by ingestion, comprising: from about 0.1 to about 10% w/v fatty acid component, where the fatty acid component comprises saturated or unsaturated C4, C5, C6, C7, C8, C9, C10, C11, or C12 fatty acids and/or salts of such fatty acids; and a therapeutic agent.
摘要:
Embodiments related to conducting a wagering game according to the rules of a base game includes defining a finite set of game indicia. In some embodiments the player plays multiple sequential game hand by placing a wager, receiving game indicia from the finite set cumulatively excluding any game indicia previously dealt, playing the game hand to completion, collecting the game indicia from the player and excluding the dealt game indicia from further play, and displaying at least the excluded game indicia or any winning combinations precluded by the excluded game indicia. In some embodiments the game hands continue in sequence until a restoration event, which may include a manually triggered restoration or an automatic restoration event, that restores the excluded game indicia. Other embodiments are also described.
摘要:
Modified natriuretic compounds and conjugates thereof are disclosed in the present invention. In particular, conjugated forms of hBNP are provided that include at least one modifying moiety attached thereto. The modified natriuretic compound conjugates retain activity for stimulating cGMP production, binding to NPR-A receptor, and in some embodiments an improved half-life in circulation as compared to unmodified counterpart natriuretic compounds. Oral, parenteral, subcutaneous, and intravenous forms of the compounds and conjugates may be prepared as treatments and/or therapies for heart conditions particularly congestive heart failure. Modifying moieties comprising oligomeric structures having a variety of lengths and configurations are also disclosed. Analogs of the natriuretic compound are also disclosed, having an amino acid sequence that is other than the native sequence.
摘要:
A method and apparatus for inspection optimization is provided. Inspection optimization improves the parametric and functional yield using optimized inspection lists for in-line semiconductor manufacturing metrology and inspection equipment.
摘要:
A new family of crystalline aluminosilicate zeolites has been synthesized. These zeolites are represented by the empirical formula. Mmn+Rr+Al(1-x)ExSiyOz where M is an alkali, alkaline earth, or rare earth metal such as lithium and strontium, R is a singly charged organoammonium cation such as the choline cation and E is a framework element such as gallium. These zeolites are similar to ZSM-18 but are characterized by unique x-ray diffraction patterns and compositions and have catalytic properties for carrying out various hydrocarbon conversion processes.
摘要翻译:已经合成了一系列结晶硅铝酸盐沸石。 这些沸石由经验公式表示。 <?in-line-formula description =“In-line Formulas”end =“lead”?> M&lt; n&gt;&lt; n +&lt; R&gt;&lt; (1-x)x 1 x x 1 x 1 x 1 x 1 x 1 x 1 x 1 x 1 x 1 line-formula description =“In-line Formulas”end =“tail”?>其中M是碱金属,碱土金属或稀土金属如锂和锶,R是单电荷的有机铵阳离子,如胆碱阳离子和 E是诸如镓的骨架元素。 这些沸石类似于ZSM-18,但是其特征在于独特的x射线衍射图和组成,并具有用于进行各种烃转化方法的催化性能。
摘要:
The collar is disconnected from the leash by activating the mechanism in the handle assembly of the leash. The collar is fitted with a short cable which extends generally radially from the collar. A small cylinder or sphere is attached to the free end of this cable. There is a flared fitting at the end of the leash opposite to the handle end. The collar and leash are connected by trapping the cylinder or sphere in the flared fitting. The leash is a sheathed cable. The tension loads in the leash are carried by the cable. One end of the cable is anchored in the leash handle. There is a second cylinder or sphere attached to its other end and located in the flared fitting when the leash and collar are connected. The second cylinder or sphere retains the first in the flared fitting which is attached to the sheath. When the mechanism in the handle is activated, the mechanism moves the sheath along the cable so that the flared fitting is moved and no longer surrounds the cylinders (or spheres) and the one can no longer retain the other and disconnection is effected. In one embodiment of the invention the mechanism in the handle is reset by pulling the sheath out of the handle.